Journal of Immunology and Regenerative Medicine

JOURNAL OF IMMUNOLOGY AND REGENERATIVE MEDICINE AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Editorial Board p.2 • Guide for Authors p.5 ISSN: 2468-4988 DESCRIPTION . As the name implies, the Journal of Immunology and Regenerative Medicine provides a forum for the publication of studies that explore the potential and essential roles of the immune system in tissue and organ development, maintenance, response to environmental stressors, response to injury, and in the processes of tissue repair and regeneration. The field of tissue engineering and regenerative medicine (TE/RM) has only recently recognized the potential benefits of modulating or instructing the immune system, rather than suppressing the immune response, as a viable strategy for promoting tissue reconstruction and improving functional outcomes. Biomaterials, both synthetic and naturally occurring, play an important role in TE/RM strategies. Therefore, it is only logical that the immune response to biomaterials is a critical consideration with respect to clinical outcomes. Similarly, the immunology community has only recently recognized the potential benefits of cross- disciplinary interactions between biomaterials and stem cell scientists who target regenerative medicine applications and clinical translation. The immunomodulatory effects of various stem and tissue progenitor cells, signaling molecules derived from extracellular matrix, and the essential contribution of regulatory macrophages, T-cells, and other immune cells in functional tissue restoration and maintenance has also taken center stage. These newly recognized targets of research and development provide exciting opportunities for immunologists, regenerative medicine scientists, biomaterial and stem cell scientists, and clinicians alike. The Journal of Immunology and Regenerative Medicine provides a venue for publication of this research. The journal will accept basic and applied research manuscripts, selected review articles, clinical study reports, and short communications for peer review and publication. The Journal of Immunology and Regenerative Medicine aims to support conferences and symposia on topics within its remit through the publication of meeting reports. The Editors would, therefore, welcome suggestions from event organisers who would like to submit a meeting report in order to increase the impact of their conference through the dissemination of research findings and discussion to a broader audience. Scope of Subject Matter: • Role of the innate and adaptive immune system in TE/RM strategies for functional tissue repair, regeneration or replacement • Cross talk between "immune cells" and "stem cells" • The host response to Biomaterials and the effect upon outcome AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/regen 1 • The role of the immune system in tissue and organ development • Nanoparticles as immune modulators • Animal models that facilitate exploration of the role of the immune system in TE/RM strategies • Clinical studies and case reports of the role of the immune system in regenerative vs non- regenerative tissues and organs • Manipulation of the innate or adaptive immune system to facilitate success TE/RM strategies • The effects of age upon the immune system and its role in TE/RM EDITORIAL BOARD . Editor-in-Chief Stephen F. Badylak, University of Pittsburgh, United States of America Regenerative Medicine, Immune response to biomaterials, Extracellular matrix and Cell: Matrix interactions Clinical translation of Regenerative Medicine technology Deputy Editor Paul J. Fairchild, University of Oxford, United Kingdom Dendritic cell biology, Cancer immunotherapy, Regenerative medicine, Allograft rejection, Induction of immunological tolerance Associate Editors Nuno Alves, Institute for Molecular and Cell Biology, Portugal Regeneration of nerves after injuries in the central nervous system Lauren D. Black III, Tufts University, United States of America Cardiac Tissue Engineering, Regenerative Medicine, Extracellular Matrix, Biomaterials, Stem Cells Jennifer Elisseeff, Johns Hopkins University, United States of America Fields of regenerative medicine and immunoengineering. Development and commercial translation of injectable biomaterials for regenerative therapies. Shukry Habib, King's College London, United Kingdom The role of Wnt signals in asymmetric cell division of embryonic and adult stem cells. Kathy Lui, The Chinese University of Hong Kong Department of Chemical Pathology, Hong Kong Cardiovascular regeneration in diabetes, development of checkpoint blocking antibodies for stem cell transplantation Jason Rock, Boston University School of Medicine, United States of America How the many different cell types of our lungs are generated during development and how they respond to normal wear and tear, acute injury and disease, identify genetic, molecular and cellular therapies for the treatment of lung disease Hēth Roderick Turnquist, University of Pittsburgh School of Medicine, United States of America Immune cell interaction with damaged tissue after injury caused by trauma and organ transplantation Advisory Board James Anderson, Case Western Reserve University, United States of America Biomaterials, medical devices, and prostheses Richard Boyd, Monash University, Australia Biotechnology, Immunology, and microbiology Bryan Brown, University of Pittsburgh, United States of America Coupling a mechanistic understanding of the host inflammatory response in injury and disease with the development of context-dependent biomaterials for regenerative medicine strategies. Clinical applications where few effective solutions currently exist, with increasing emphasis upon unmet clinical needs in women’s health Tse-Ching Chen, Chang Gung Medical Foundation, Taiwan Clinicopathologic study of intrahepatic cholangiocarcinoma, Investigation into the molecular mechanisms of hepatocarcinogenesis, Design of tolerogenic vaccine, Study of regulatory T cells in autoimmune disease, asthma, infectious disease and cancers and Identification of the molecular signature of adaptive regulatory T cells George J. Christ, University of Virginia, United States of America Development of basic and translational tissue engineering and regenerative medicine approaches to organ and tissue repair, reconstruction and replacement, with a focus on the musculoskeletal system, vasculature and lower urinary tract. Internationally recognized expert in muscle physiology Mark Coles, University of Oxford, United Kingdom Checkpoint blockade as a therapeutic modality, Role of fibroblasts in immunomodulation, CAR T cell therapy AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/regen 2 Anna Mae Diehl, Duke University, United States of America Liver injury and repair. To learn more about the mechanisms that regulate this process, research studies cultured cells, animal models of acute and chronic liver damage and samples from patients with various types of liver disease. Research is particularly interested in fatty liver diseases, such as alcoholic fatty liver disease and nonalcoholic fatty liver disease (NAFLD) Stuart Forbes, The University of Edinburgh, United Kingdom Liver stem cells and regeneration Donald O. Freytes, North Carolina State University, United States of America Regenerative medicine, tissue engineering, stem cells, extracellular matrix, biomaterials Lior Gepstein, Technion Israel Institute of Technology, Israel Cardiac Stem Cells, Cardiac Extracellular Matrix and its’ Biologic Effects, 3-Dimensional Scaffolds for Tissue Engineering Matthew Griffin, National University of Ireland Galway, Ireland Immunological Properties of Dendritic Cells in Acute Kidney Injury, Interactions Between Dendritic Cells and T-cells in Acute Renal Obstruction Robert Guldberg, Georgia Institute of Technology, United States of America Bioengineering Cartilage and bone tissue engineering Øyvind Halaas, Norwegian University of Science and Technology, Norway Engineering of immune organs and uses thereof, with special emphasis on lymph nodes and cancer immunotherapy. T cell immunology, especially against cancers, organs-on-chip systems in general, biomaterials, microfluidics, organogenesis, tissue microenvironments, biosensors, nanomedicine/ drug delivery, and regenerative medicine and nanomedicine Jacob Hanna, Weizmann Institute of Science, Israel Pluripotent Stem Cells, Regulation of pluripotency, Tissue and Organ Development Kirk Hansen, University of Colorado Denver, United States of America Developing strategies for the detection and characterization of extracellular proteins in health and disease. Research seeks to understand underlying mechanisms of tissue microenvironments, including innate immunity, in disease processes using mass spectrometry Neil Henderson, The University of Edinburgh Centre for Inflammation Research, United Kingdom Cellular and molecular mechanisms that drive organ fibrosis, and also the pathways which are responsible for efficient wound healing and healthy tissue regeneration following injury Christopher M. Jewell, University of Maryland at College Park, United States of America Immunology and biomaterials to decipher the interactions between synthetic materials and immune tissues. Research seeks to improve therapeutic vaccines for cancer and autoimmune diseases such as multiple sclerosis and type 1 diabetes Benjamin Keselowsky, University of Florida, United States of America Immune Engineering, Biomaterials Darrell N. Kotton, Boston University, United States of America

Load more